Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Shrewsbury native Gabby Demac was diagnosed with stage 3 Hodgkin's lymphoma. She won that fight, and now wants to give back ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

Dana-Farber Brigham Cancer Center-led phase 3 clinical trial shows that pembrolizumab before and after standard-of-care surgery significantly extends ...

She is partnering with Dana-Farber to run all six major marathons ... alongside receiving chemotherapy and undergoing surgery. For patients like Montgomery, it is only a matter of time before ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report ... inhibitor, plus chemotherapy with or without immunotherapy for advanced salivary gland cancer,” in the ...

From sitting in a hospital bed to running 26.2 miles, Griffin Shoemaker is checking items off his to-do list following his ...